SCHEMBL4818310

SCHEMBL4818310

CC(C)(C)c1cccc2ccccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.48
ALDH1A1 P00352 5/20 0.48
CYP2A6 P11509 4/20 0.48
CA2 P00918 2/20 0.48
TSHR P16473 4/20 0.46
TDP1 Q9NUW8 2/20 0.46
HSD17B10 Q99714 3/20 0.46
CYP1A2 P05177 4/20 0.42
CYP3A4 P08684 1/20 0.42
HPGD P15428 1/20 0.42
KEAP1 Q14145 1/20 0.42
HPRT1 P00492 1/20 0.42
GABRA1 P14867 1/20 0.41
GABRB2 P47870 1/20 0.41
ACP3 P15309 1/20 0.41
KDM4E B2RXH2 1/20 0.40
CA1 P00915 1/20 0.40
CA9 Q16790 1/20 0.40
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29972825 1.00 KIF11 (0.48) KIF11ALDH1A1CYP2A6CA2TSHR
SCHEMBL252402 1.00 KIF11 (0.48) KIF11ALDH1A1CYP2A6CA2TSHR
SCHEMBL3779052 0.98 KIF11 (0.47) KIF11ALDH1A1CYP2A6CA2TSHR
SCHEMBL3779049 0.98 KIF11 (0.47) KIF11ALDH1A1CYP2A6CA2TSHR
Formaldehyde SCHEMBL28441436 0.93 KIF11 (0.44) KIF11ALDH1A1CYP2A6CA2TSHR
Formic Acid SCHEMBL27662627 0.88 CA2 (0.43) KIF11ALDH1A1CYP2A6CA2TSHR
SCHEMBL285919 0.87 HPRT1 (0.58) KIF11ALDH1A1CYP2A6CA2TSHR
SCHEMBL2015958 0.87 HPRT1 (0.58) KIF11ALDH1A1CYP2A6CA2TSHR
SCHEMBL28297056 0.85 ALDH1A1 (0.48) KIF11ALDH1A1CYP2A6CA2TSHR
Cyclobutanol SCHEMBL9815506 0.83 CA2 (0.39) KIF11ALDH1A1CA2TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7358396-B2 Preparation of optically active amines BASF AKTIENGESELLSCHAFT (DE) 2008-04-15 US disclosed
US-20070155971-A1 Chiral diphosphorus compounds and their transition metal complexes Source Global, PBC 2007-07-05 US disclosed
US-7193092-B2 Chiral diphosphorus compounds and their transition metal complexes LANXESS DEUTSCHLAND GMBH (DE) 2007-03-20 US disclosed
US-7078226-B1 Method for producing optically active amines BASF AKTIENGESELLSCHAFT (DE) 2006-07-18 US disclosed
US-20060122429-A1 Preparation of optically active amines DITRICH KLAUS 2006-06-08 US disclosed
EP-1400527-B1 Chiral diphosphorus compounds and transition metal complexes thereof LANXESS DEUTSCHLAND GMBH (DE) 2006-03-22 EP disclosed
EP-1398319-B1 Chiral monophosphorus compounds and transition metal complexes thereof LANXESS DEUTSCHLAND GMBH (DE) 2005-11-09 EP disclosed
US-20050080047-A1 Chiral diphosphorus compounds and their transition metal complexes LANXESS DEUTSCHLAND GMBH (DE) 2005-04-14 US disclosed
EP-1232279-B1 METHOD FOR PRODUCING OPTICALLY ACTIVE AMINES BASF AG (DE) 2005-03-02 EP disclosed
US-20040127430-A1 Chiral monophosphorus compounds and their transition metal complexes LANXESS DEUTSCHLAND GMBH (DE) 2004-07-01 US disclosed
EP-1400527-A1 Chiral diphosphorus compounds and transition metal complexes thereof Bayer Chemicals AG (DE) 2004-03-24 EP disclosed
EP-1398319-A1 Chiral monophosphorus compounds and transition metal complexes thereof Bayer Chemicals AG (DE) 2004-03-17 EP disclosed
EP-1232279-A2 METHOD FOR PRODUCING OPTICALLY ACTIVE AMINES BASF AKTIENGESELLSCHAFT (DE) 2002-08-21 EP disclosed
EP-0906324-B1 CARBOHYDRATE DERIVATIVES AND THEIR SOLID-PHASE SYNTHESIS BASF AG (DE) 2001-08-01 EP disclosed
US-6242583-B1 COUPLING CARBOHYDRATE COMPOUNDS IN PRESENCE OF PROMOTER TO A FUNCTIONALIZED SOLID SUPPORT BASF AKTIENGESELLSCHAFT (DE) 2001-06-05 US disclosed
WO-2001038292-A2 METHOD FOR PRODUCING OPTICALLY ACTIVE AMINES BASF AKTIENGESELLSCHAFT (DE) 2001-05-31 WO disclosed
US-5990320-A Optically active diphosphine ligands BASF AKTIENGESELLSCHAFT (DE) 1999-11-23 US disclosed
EP-0906324-A1 CARBOHYDRATE DERIVATIVES AND THEIR SOLID-PHASE SYNTHESIS BASF AKTIENGESELLSCHAFT (DE) 1999-04-07 EP disclosed
WO-1997045436-A1 CARBOHYDRATE DERIVATIVES AND THEIR SOLID-PHASE SYNTHESIS BASF AKTIENGESELLSCHAFT (DE) 1997-12-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122429-A1 Preparation of optically active amines MAOA, MAOB, NAAA KIF11 1540/4885ALDH1A1 283/4885CYP2A6 753/4885
US-20040127430-A1 Chiral monophosphorus compounds and their transition metal complexes MDM4, MPHOSPH6, AP3M1 KIF11 2512/4885ALDH1A1 4060/4885CYP2A6 1161/4885
US-20070155971-A1 Chiral diphosphorus compounds and their transition metal complexes CDIPT, DCPS, PIN1 KIF11 2079/4885ALDH1A1 3235/4885CYP2A6 701/4885
US-20050080047-A1 Chiral diphosphorus compounds and their transition metal complexes CDIPT, DCPS, PIN1 KIF11 2079/4885ALDH1A1 3235/4885CYP2A6 701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.